HMGB1 and Hyperglycemia: Our study holds particular significance, as it not only determined the potential therapeutic benefits of targeting HMGB1 to address hyperglycemia and the DM epidemic, but also represents the inaugural study to characterize promising mechanisms underlying the action of HMGB1 knockdown on hyperglycemia and DM.